Latest Press Releases January 8, 2026 News Novotech appoints Anand Tharmaratnam as new CEO Singapore, 8 January 2026 – Novotech, a globally recognized full-service biotech... Read more December 16, 2025 News Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution Sydney, Australia, December 2025, Novotech, a leading global full-service clinic... Read more October 31, 2025 News Novotech Maps Global Growth in Radiopharmaceutical Trials Sydney, Australia, October 2025 — Novotech, a leading global clinical research o... Read more August 29, 2025 News Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue… SYDNEY, Australia – August 28, 2025, Novotech, a globally recognized full-servic... Read more View all Press Releases Latest Disease Reports April 19, 2025 Report Obesity: Global Clinical Trial Landscape (2025) Explore the evolving treatment landscape for obesity through Novotech CRO’s latest disease report.... Download April 10, 2025 Report Idiopathic Pulmonary Fibrosis: Global Clinical Trial Landscape (2025) Discover the latest advancements in Idiopathic Pulmonary Fibrosis through Novotech CRO's in-depth disease analysis.... Download February 26, 2025 Report Hepatitis B: Global Clinical Trial Landscape (2025) Discover the latest advancements in Hepatitis B through Novotech CRO's in-depth disease analysis.... Download January 7, 2025 Report Triple-Negative Breast Cancer: Global Clinical Trial Landscape (2024) Discover the latest advancements in triple-negative breast cancer through Novotech CRO's in-depth disease analysis.... Download View all Disease Reports Latest White Papers December 4, 2025 Whitepaper The Starting Point of Breakthrough Therapies: A Deep Dive into Early-Phase Oncology Early-phase oncology trials mark the most critical and fast-evolving stage of cancer research... Download October 15, 2025 Whitepaper Therapeutic Radiopharmaceuticals: Download 2025 Global Report Unlocking the Future of Precision Oncology with Therapeutic Radiopharmaceuticals.... Download July 2, 2025 Whitepaper 2025 Global Report for In-Vivo CAR Cell Therapy Explore global trends shaping in-vivo CAR therapies—delivery innovations, clinical trial momentum, and regulatory strategies across oncology and autoimmune diseases.... Download June 12, 2025 Whitepaper Live Biotherapeutic Products Whitepaper 2025 Live biotherapeutic products (LBPs) are gaining momentum in the drug development space, emphasisin... Download View all White Papers Latest Webinars February 19, 2026 Webinar Translating Early-Phase Radiopharma Innovation into Clinical Success: Perspectives from… How do you turn early-phase radiopharmaceutical innovation into clinical success? This expert-led webinar will explore how early… Watch November 18, 2025 Webinar Early Phase Excellence: Navigating B Cell Therapies in Autoimmune Conditions This webinar will explore the evolving landscape of B cell–targeting therapies in autoimmune diseases. Expert panelists will… Watch October 30, 2025 Webinar Obesity, from the bench to the bedside: Science, Solutions, and Stories This webinar will explore the biological, clinical, and societal impact of obesity while highlighting opportunities to advance… Watch June 26, 2025 Webinar Mitigating Risk with Ex-US Clinical Trials This expert-led webinar explores how ex-US clinical trials can help biotech and mid-size pharma companies accelerate development… Watch View all webinars Latest Podcasts April 7, 2026 Podcast Reducing Study Startup Delays: A Practical Guide Learn how to identify and manage study startup delays in clinical trials, with practical guidance from Novotech’s study start-up expert.... March 6, 2026 Podcast Global Strategies for Radiopharmaceutical Clinical Trials Radiopharmaceutical trials are growing quickly, but execution is rarely straightforward. In this episode, Novotech’s Senior Project Manage Stacey Lee explains... March 4, 2026 Podcast Key Early-Phase Decisions in B Cell–Targeted Autoimmune Therapies B cell–targeted therapies are becoming an important focus in autoimmune drug development. Early-phase decisions can have lasting implications for safety,... February 9, 2026 Podcast Obesity, From Bench to Bedside: Science, Solutions, and Stories Obesity drug development is moving faster than any other metabolic area and success now depends on more than efficacy alone.... View all Podcasts Latest Events June 22-25, 2026 Events BIO International ConventionSan Diego, California Read More May 29-June 1, 2026 Events ASCO 2026Chicago, Illinois Read More May 7-8, 2026 Events CRM Trial Connect 2026 Kuala Lumpur, Malaysia Read More May 6-7, 2026 Events Outsourcing in Clinical Trials (OCT) Europe 2026Barcelona, Spain Read More View all events Latest Articles April 9, 2026 Article Key Insights into the Science, Strategy, and Future of in Vivo CAR-T In vivo CAR-T therapies are an emerging approach with the potential to reshape autoimmune disease treatment if key scientific and... Read more March 20, 2026 Article Breaking Through the Checkpoint Blockade in Immuno-Oncology Immuno-oncology is moving beyond first-generation checkpoint inhibitors, with new approaches such as bispecific antibodies, T-cell engagers, and bi... Read more January 28, 2026 Article South Korea and Australia Offer Solutions for Radiopharmaceutical Trial Bottlenecks Published in Clinical Trials Arena, this article examines how Australia and South Korea are addressing key bottlenecks in radiopharmaceuti... Read more January 9, 2026 Article The Future of Obesity Drugs Starts in Preclinical Discovery The future of obesity drugs is being shaped long before clinical trials, in preclinical discovery.... Read more View all articles Latest Blogs April 29, 2026 Blog Understanding Expedited IND Review Pathways in China: Why Speed Needs the Right Foundations China’s expedited IND pathways can shorten NMPA timelines, but sponsors need strategy, data readiness and local alignment from the outset.... Read more April 28, 2026 Blog FDA Draft Guidance on New Approach Methodologies (NAMs): A Structural Shift in Drug Development… Explore what the FDA’s draft NAMs guidance means for nonclinical strategy, regulatory planning, and decision-making in drug development.... Read more April 21, 2026 Blog China’s eCTD Shift: A Turning Point for How Submissions Are Built China’s eCTD transition is reshaping how NMPA submissions are built, maintained and reviewed. Learn what it means for global and... Read more April 16, 2026 Blog The EU Biotech Act: What It Means for Biotechnology Innovation and Clinical Development in Europe Understand how the EU Biotech Act may impact clinical trial strategy, regulatory pathways, and biotech CRO partnerships in Europe.... Read more View all blogs Latest Case Studies April 20, 2026 Case Study Accelerating FIH mRNA Immunotherapy Trials Across APAC OverviewA US biotechnology company partnered with Novotech to initiate two first-in-human mRNA oncology trials in Australia and... Read More March 20, 2026 Case Study Accelerating First-in-Human Start-Up for a Complex GMO Oncology Clinical Trial OverviewOncology clinical trial was designed to evaluate safety, tolerability, dose escalation, pharmacokinetics (PK), pharmacod... Read More January 22, 2026 Case Study Phase III IPF Clinical Trial Delivered Across Asia-Pacific A multinational Phase III, randomized, double-blind, placebo-controlled IPF study conducted across Australia, South Korea, Hong Kong, and... Read More September 5, 2025 Case Study Accelerating Obesity Drug Development in Australia and New Zealand with Novotech Addressing a Global Health PriorityObesity is one of the fastest-growing global health challenges, affecting more than 1 billion... Read More View all case studies Latest Frequently Asked Questions December 4, 2025 FAQ How Is Early-phase Oncology Shaping The Next Generation Of Cancer Therapies? Gain insight into the emerging platforms, regulatory shifts, and clinical advances that are redefining early-phase oncology.... Read More October 15, 2025 FAQ How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology? Uncover the science, clinical applications, and global momentum behind this rapidly growing treatment modality.... Read More July 2, 2025 FAQ What makes in-vivo CAR therapies the next frontier in cell therapy? Explore key questions and answers to learn how this innovative approach is transforming treatment possibilities.&nb... Read More June 12, 2025 FAQ FAQs on Live Biotherapeutic Products Live biotherapeutic products contain a single species or consortium of live microorganisms such as bacteria or yeast isolated from human... Read More View all Frequently Asked Questions